PDCD1 and gastric cancer: One recent study [28] reported that 13 patients with gastric cancer had a higher TLS score after receiving programmed cell death 1 (PD1) blockade therapy, suggesting that the generation of TLSs could occur after immune therapy which was also shown to be a biomarker for good responsiveness of immune therapy.